Theravance Biopharma TBPH Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's software and technology licenses, net?
- Theravance Biopharma (TBPH) reported software and technology licenses, net of $25.3M in Q1 2026.
- How has Theravance Biopharma's software and technology licenses, net changed year-over-year?
- Theravance Biopharma's software and technology licenses, net increased by 83.0% year-over-year, from $13.82M to $25.3M.
- What is the long-term trend for Theravance Biopharma's software and technology licenses, net?
- Over 5 years (2020 to 2025), Theravance Biopharma's software and technology licenses, net has grown at a 59.0% compound annual growth rate (CAGR), from $2.45M to $24.88M.